Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Transplantation Conditioning"" wg kryterium: Temat


Tytuł :
Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
Autorzy :
Cheon J; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Lee YJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Kweon K; Department of Psychiatry, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Koh S; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Min YJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Park SH; Department of Laboratory Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Lee SH; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Kim HJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea.
Choi Y; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwandoro, Dong-gu, Ulsan, 44033, South Korea. .
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Feb; Vol. 29 (2), pp. 975-986. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*adverse effects
Quality of Life/*psychology
Survivors/*statistics & numerical data
Transplantation Conditioning/*adverse effects
Transplantation, Homologous/*adverse effects
Female ; Hematopoietic Stem Cell Transplantation/methods ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Middle Aged ; Republic of Korea ; Retrospective Studies ; Risk Factors ; Survival Rate ; Transplantation Conditioning/methods ; Transplantation Conditioning/mortality ; Transplantation, Homologous/methods ; Transplantation, Homologous/mortality
Czasopismo naukowe
Tytuł :
[Potential of ultrasound in allogeneic stem cell transplantation and transplant-related complications].
Autorzy :
Trenker C; Klinik für Hämatologie, Onkologie und Immunologie, UKGM Marburg und Philipps-Universität Marburg.
Dietrich CF; Klinik Beauside, Departement für Allgemeine Innere Medizin, Hirslanden Bern.
Klein S; Universitätsklinikum Mannheim, III. Medizinische Klinik.
Safai Zadeh E; Interdisziplinäres Ultraschallzentrum, UKGM Marburg.
Sohlbach K; Klinik für Hämatologie, Onkologie und Immunologie, UKGM Marburg und Philipps-Universität Marburg.
Neubauer A; Klinik für Hämatologie, Onkologie und Immunologie, UKGM Marburg und Philipps-Universität Marburg.
Burchert A; Klinik für Hämatologie, Onkologie und Immunologie, UKGM Marburg und Philipps-Universität Marburg.
Görg C; Interdisziplinäres Ultraschallzentrum, UKGM Marburg.
Pokaż więcej
Transliterated Title :
Potenzial des Ultraschalls bei allogener Stammzelltransplantation und transplantationsassoziierten Komplikationen.
Źródło :
Zeitschrift fur Gastroenterologie [Z Gastroenterol] 2021 Apr; Vol. 59 (4), pp. 336-344. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Transplantation Conditioning*
Ultrasonography/*methods
Humans ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł :
Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
Autorzy :
Myrdal OH; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway. .; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. .
Diep PP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pediatric Oncology and Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Department of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Ruud E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pediatric Oncology and Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Brinch L; Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Massey RJ; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Edvardsen E; Department of Physical Performance, The Norwegian School of Sport Sciences, Oslo, Norway.; Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Kongerud J; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lund MB; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Sikkeland LI; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Apr; Vol. 29 (4), pp. 1959-1967. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiorespiratory Fitness/*physiology
Hematopoietic Stem Cell Transplantation/*methods
Survivors/*statistics & numerical data
Transplantation Conditioning/*methods
Adolescent ; Adult ; Cohort Studies ; Cross-Sectional Studies ; Female ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Middle Aged ; Survival Analysis ; Transplantation Conditioning/mortality ; Young Adult
Czasopismo naukowe
Tytuł :
Outcomes of second hematopoietic stem cell transplantation using reduced-intensity conditioning in an outpatient setting.
Autorzy :
Jaime-Pérez JC; Department of Hematology, Internal Medicine Division, Dr. Jose Eleuterio Gonzalez University Hospital and School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Picón-Galindo E; Department of Hematology, Internal Medicine Division, Dr. Jose Eleuterio Gonzalez University Hospital and School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Herrera-Garza JL; Department of Hematology, Internal Medicine Division, Dr. Jose Eleuterio Gonzalez University Hospital and School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Gómez-Almaguer D; Department of Hematology, Internal Medicine Division, Dr. Jose Eleuterio Gonzalez University Hospital and School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2021 Feb; Vol. 39 (1), pp. 87-96. Date of Electronic Publication: 2020 Oct 03.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Ambulatory Care*
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Adult ; Allografts ; Autografts ; Chronic Disease ; Disease-Free Survival ; Female ; Graft vs Host Disease/etiology ; Graft vs Host Disease/mortality ; Humans ; Male ; Middle Aged ; Neutropenia/etiology ; Neutropenia/mortality ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen.
Autorzy :
Chiusolo P; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Bregante S; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Giammarco S; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Lamparelli T; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Casarino L; Istituto di Medicina Legale, Universita' di Genova, Genova, Italy.
Dominietto A; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Raiola AM; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Metafuni E; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Di Grazia C; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Gualandi F; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Sora F; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Laurenti L; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Sica S; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Barosi G; Centro per lo Studio della Mielofibrosi, IRCCS Policlinico San Matteo, Pavia, Italy.
Guolo F; Istituto di Ematologia, Universita' di Genova, Genova, Italy.
Rossi M; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Rossi E; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Vannucchi A; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Universita' di Firenze, AOU Careggi, Florence, Italy.
Signori A; Sezione di Biostatistica, Dipartimento di Scienze della Salute, Universita' di Genova, Genova, Italy.
De Stefano V; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Bacigalupo A; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Angelucci E; UO Ematologia e Trapianto di Midollo Osseo, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 Feb 01; Vol. 96 (2), pp. 234-240. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Transplantation Chimera*
Transplantation Conditioning*
Primary Myelofibrosis/*mortality
Primary Myelofibrosis/*therapy
Adult ; Aged ; Allografts ; Busulfan/administration & dosage ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Melphalan/administration & dosage ; Middle Aged ; Splenectomy ; Survival Rate ; Thiotepa/administration & dosage
Czasopismo naukowe
Tytuł :
Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients.
Autorzy :
Lazarow H; Clinical Nutrition Support Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. .
Singer R; Clinical Nutrition Support Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Compher C; School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.
Gilmar C; Department of Healthcare Epidemiology, Infection Prevention and Control, University of Pennsylvania, Philadelphia, PA, USA.
Kucharczuk CR; Department of Advanced Practice, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Mangan P; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Salam K; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Cunningham K; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Stadtmauer EA; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Landsburg DJ; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Feb; Vol. 29 (2), pp. 997-1003. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*adverse effects
Malnutrition/*therapy
Nutritional Support/*methods
Parenteral Nutrition/*methods
Transplantation Conditioning/*adverse effects
Transplantation, Autologous/*adverse effects
Aged ; Cohort Studies ; Enteral Nutrition/methods ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Male ; Malnutrition/etiology ; Middle Aged ; Prospective Studies ; Transplantation Conditioning/methods ; Transplantation, Autologous/methods
Czasopismo naukowe
Tytuł :
Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study.
Autorzy :
Mori Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Sasaki K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Ito Y; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Kuriyama T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Ueno T; Department of Internal Medicine, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
Kadowaki M; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Aoki T; Department of Hematology, Harasanshin Hospital, Fukuoka, Japan.
Sugio T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Yoshimoto G; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Maeda T; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Nagafuji K; Division of Hematology/Oncology, Kurume University School of Medicine, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .
Pokaż więcej
Corporate Authors :
Fukuoka Blood and Marrow Transplantation Group
Źródło :
Annals of hematology [Ann Hematol] 2021 Jan; Vol. 100 (1), pp. 197-208. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*trends
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*trends
Adolescent ; Adult ; Aged ; Female ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prognosis ; Retreatment/mortality ; Retreatment/trends ; Retrospective Studies ; Survival Rate/trends ; Transplantation Conditioning/mortality ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial.
Autorzy :
Seydoux C; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
Medinger M; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland. .
Gerull S; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
Halter J; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
Heim D; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
Chalandon Y; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Levrat SM; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Schanz U; Department of Medical Oncology and Hematology, Stem-/Immune- cell-transplant Unit, University Hospital of Zurich, Zurich, Switzerland.
Nair G; Department of Medical Oncology and Hematology, Stem-/Immune- cell-transplant Unit, University Hospital of Zurich, Zurich, Switzerland.
Ansari M; Department Women, Children and Adolescent, Unit of Oncology and Hematology Pediatric, University Hospital of Geneva, Geneva, Switzerland.; Cansearch Research Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Simon P; Clinical Trials Unit, Department of Clinical Research, Basel University, Basel, Switzerland.
Passweg JR; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland. .
Cantoni N; Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Jan; Vol. 100 (1), pp. 209-216. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Busulfan/*administration & dosage
Cyclophosphamide/*administration & dosage
Hematologic Neoplasms/*therapy
Hematopoietic Stem Cell Transplantation/*methods
Immunosuppressive Agents/*administration & dosage
Transplantation Conditioning/*methods
Adult ; Aged ; Busulfan/adverse effects ; Chemical and Drug Induced Liver Injury/diagnosis ; Chemical and Drug Induced Liver Injury/mortality ; Cyclophosphamide/adverse effects ; Drug Therapy, Combination ; Female ; Hematologic Neoplasms/drug therapy ; Hematologic Neoplasms/mortality ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Prospective Studies ; Transplantation Conditioning/mortality ; Transplantation, Homologous/methods ; Transplantation, Homologous/mortality ; Young Adult
Czasopismo naukowe
Tytuł :
Experimental Competitive Bone Marrow Transplant Assays.
Autorzy :
Hétu-Arbour R; Institut National de la Recherche Scientifique, Laval, QC, Canada.
Bouali S; Institut National de la Recherche Scientifique, Laval, QC, Canada.
Heinonen KM; Institut National de la Recherche Scientifique, Laval, QC, Canada. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2185, pp. 195-214.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Marrow Transplantation*
Flow Cytometry*
Transplantation Conditioning*
Whole-Body Irradiation*
Transplantation Chimera/*blood
Animals ; Mice
Czasopismo naukowe
Tytuł :
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
Autorzy :
Myllymäki M; Division of Hematological Malignancies, Department of Medical Oncology, and.
Redd R; Department of Data Sciences, Dana-Farber Cancer Institute, Boston MA.
Reilly CR; Division of Hematological Malignancies, Department of Medical Oncology, and.
Saber W; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
Spellman SR; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN.
Gibson CJ; Division of Hematological Malignancies, Department of Medical Oncology, and.
Hu ZH; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
Wang T; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN.
Orr EH; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.
Grenier JG; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.
Chen MM; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.
Steensma DP; Division of Hematological Malignancies, Department of Medical Oncology, and.
Cutler C; Division of Hematological Malignancies, Department of Medical Oncology, and.
De Vivo I; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.; Channing Division of Network Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston, MA; and.
Antin JH; Division of Hematological Malignancies, Department of Medical Oncology, and.
Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston MA.
Agarwal S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Lindsley RC; Division of Hematological Malignancies, Department of Medical Oncology, and.
Pokaż więcej
Źródło :
Blood [Blood] 2020 Dec 24; Vol. 136 (26), pp. 3070-3081.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Myelodysplastic Syndromes*/genetics
Myelodysplastic Syndromes*/metabolism
Myelodysplastic Syndromes*/mortality
Myelodysplastic Syndromes*/therapy
Stem Cell Transplantation*
Telomere*/genetics
Telomere*/metabolism
Telomere Homeostasis*
Transplantation Conditioning*
Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male ; Melphalan/administration & dosage ; Middle Aged ; Predictive Value of Tests ; Survival Rate
Czasopismo naukowe
Tytuł :
Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.
Autorzy :
Esteves I; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Santos FPS; Hospital Israelita Albert Einstein, São Paulo, Brazil.
Ribeiro AAF; Hospital Israelita Albert Einstein, São Paulo, Brazil.
Seber A; Hospital Samaritano, São Paulo, Brazil.
Sugawara EK; Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil.
Sobrinho JJDN; Hospital Israelita Albert Einstein, São Paulo, Brazil.
Barros JC; Transplantation, Hospital Dr. Euryclides de Jesus Zerbini, São Paulo, Brazil.
Oliveira JSR; Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Fernandes JF; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Bone Marrow Transplantation Unit, Itaci Hospital, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
Hamerschlak N; Hospital Israelita Albert Einstein, São Paulo, Brazil.
Andersson BS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
de Lima M; Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio, USA.
Kerbauy FR; Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Dec; Vol. 38 (5), pp. 773-781. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article
MeSH Terms :
Busulfan/*administration & dosage
Busulfan/*adverse effects
Hepatic Veno-Occlusive Disease/*etiology
Transplantation Conditioning/*adverse effects
Administration, Intravenous ; Administration, Oral ; Adolescent ; Area Under Curve ; Busulfan/pharmacokinetics ; Child ; Child, Preschool ; Controlled Clinical Trials as Topic ; Disease Susceptibility ; Female ; Hematologic Diseases/diagnosis ; Hematologic Diseases/therapy ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hepatic Veno-Occlusive Disease/diagnosis ; Hepatic Veno-Occlusive Disease/epidemiology ; Hepatic Veno-Occlusive Disease/mortality ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Prognosis ; Transplantation Conditioning/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Haploidentical stem cell transplant with post-transplantation cyclophosphamide and mini-dose methotrexate in children.
Autorzy :
Medina D; Stem Cell Transplant, Fundación Valle del Lili, Cali, Colombia. Electronic address: .
Estacio M; Stem Cell Transplant, Fundación Valle del Lili, Cali, Colombia. Electronic address: .
Rosales M; Stem Cell Transplant, Fundación Valle del Lili, Cali, Colombia.
Manzi E; Stem Cell Transplant, Fundación Valle del Lili, Cali, Colombia.
Pokaż więcej
Źródło :
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2020 Dec; Vol. 13 (4), pp. 208-213. Date of Electronic Publication: 2020 Mar 20.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*/etiology
Graft vs Host Disease*/mortality
Graft vs Host Disease*/therapy
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Hematopoietic Stem Cell Transplantation*
Histocompatibility*
Transplantation Conditioning*
Unrelated Donors*
Cyclophosphamide/*administration & dosage
Methotrexate/*administration & dosage
Adolescent ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Male ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
Autorzy :
Gluckman E; Monacord, Centre Scientifique de Monaco, Monaco; Eurocord, Hôpital Saint Louis, Universite Paris Diderot, Paris, France. Electronic address: .
Cappelli B; Monacord, Centre Scientifique de Monaco, Monaco; Eurocord, Hôpital Saint Louis, Universite Paris Diderot, Paris, France.
Scigliuolo GM; Monacord, Centre Scientifique de Monaco, Monaco; Eurocord, Hôpital Saint Louis, Universite Paris Diderot, Paris, France.
De la Fuente J; Department of Pediatrics, St Mary's Hospital, Imperial College, London, UK.
Corbacioglu S; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
Pokaż więcej
Źródło :
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2020 Dec; Vol. 13 (4), pp. 181-188. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Unrelated Donors*
Anemia, Sickle Cell/*mortality
Anemia, Sickle Cell/*therapy
Graft vs Host Disease/*mortality
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Disease-Free Survival ; Europe/epidemiology ; Female ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Humans ; Lymphocyte Depletion ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Tytuł :
Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis.
Autorzy :
Ma L; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Han X; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Jiang S; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Meng Q; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Zhang L; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Bao H; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Pokaż więcej
Źródło :
Hematology (Amsterdam, Netherlands) [Hematology] 2020 Dec; Vol. 25 (1), pp. 356-365.
Typ publikacji :
Comparative Study; Journal Article; Systematic Review; Video-Audio Media
MeSH Terms :
Graft vs Host Disease*/etiology
Graft vs Host Disease*/mortality
Graft vs Host Disease*/therapy
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Unrelated Donors*
Adult ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis.
Autorzy :
Hashmi H; Division of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA. Electronic address: .
Bhandari S; Division of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Kumar R; Division of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Tripathi P; Division of Infectious Disease, University of Louisville, Louisville, KY, USA.
Rhodes JB; Division of Clinical Oncology Pharmacy, James Graham Brown Cancer Center, University of Louisville Hospital, Louisville, KY, USA.
Figg L; Division of Clinical Oncology Pharmacy, James Graham Brown Cancer Center, University of Louisville Hospital, Louisville, KY, USA.
Baize T; Division of Clinical Oncology Pharmacy, James Graham Brown Cancer Center, University of Louisville Hospital, Louisville, KY, USA.
Krem MM; Division of Hematology and Blood and Marrow Transplant, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Hegazi M; Division of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Emmons R; Division of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Pokaż więcej
Źródło :
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2020 Dec; Vol. 13 (4), pp. 232-237. Date of Electronic Publication: 2020 May 08.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Graft vs Host Disease/*prevention & control
Tacrolimus/*administration & dosage
Adult ; Aged ; Female ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/etiology ; Humans ; Incidence ; Infusions, Intravenous ; Male ; Middle Aged ; Retrospective Studies ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation.
Autorzy :
Wada F; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Nishikori M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. .
Hishizawa M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Watanabe M; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
Aiba A; Department of Hematology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
Kitano T; Department of Hematology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
Shimazu Y; Department of Hematology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Shindo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Kondo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Takaori-Kondo A; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Nov; Vol. 112 (5), pp. 609-613. Date of Electronic Publication: 2020 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Busulfan/*adverse effects
Central Nervous System Neoplasms/*therapy
Hematopoietic Stem Cell Transplantation/*adverse effects
Lymphoma/*therapy
Thiotepa/*adverse effects
Thrombocytopenia/*etiology
Transplantation Conditioning/*adverse effects
Adult ; Aged ; Busulfan/administration & dosage ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Male ; Middle Aged ; Thiotepa/administration & dosage ; Time Factors ; Transplantation Conditioning/methods ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia.
Autorzy :
Wong JYC; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA.
Filippi AR; Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy. Electronic address: .
Scorsetti M; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Hospital-IRCCS, Rozzano, Milan, Italy.
Hui S; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA.
Muren LP; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus N, Denmark.
Mancosu P; Department of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Hospital-IRCCS, Rozzano, Milan, Italy.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Oct; Vol. 21 (10), pp. e477-e487.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Bone Marrow Transplantation*
Lymphatic Irradiation*/adverse effects
Transplantation Conditioning*/adverse effects
Transplantation Conditioning*/trends
Bone Marrow/*radiation effects
Leukemia, Myeloid, Acute/*therapy
Humans ; Radiation Dosage ; Radiotherapy Planning, Computer-Assisted ; Treatment Outcome ; Whole-Body Irradiation/adverse effects
Czasopismo naukowe
Tytuł :
CD52-negative T cells predict acute graft-versus-host disease after an alemtuzumab-based conditioning regimen.
Autorzy :
Woelfinger P; Department of Hematology, Oncology and Pneumology, University Cancer Center Mainz (UCT), University Medical Center Mainz, Mainz, Germany.
Epp K; Department of Hematology, Oncology and Pneumology, University Cancer Center Mainz (UCT), University Medical Center Mainz, Mainz, Germany.
Schaefer L; Department of Hematology, Oncology and Pneumology, University Cancer Center Mainz (UCT), University Medical Center Mainz, Mainz, Germany.
Kriege D; Department of Hematology, Oncology and Pneumology, University Cancer Center Mainz (UCT), University Medical Center Mainz, Mainz, Germany.
Theobald M; Department of Hematology, Oncology and Pneumology, University Cancer Center Mainz (UCT), University Medical Center Mainz, Mainz, Germany.
Bopp T; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Wagner-Drouet EM; Department of Hematology, Oncology and Pneumology, University Cancer Center Mainz (UCT), University Medical Center Mainz, Mainz, Germany.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Oct; Vol. 191 (2), pp. 253-262. Date of Electronic Publication: 2020 May 14.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Alemtuzumab/*administration & dosage
CD52 Antigen/*blood
Graft vs Host Disease/*blood
T-Lymphocytes, Regulatory/*metabolism
Acute Disease ; Adult ; Aged ; Allografts ; Female ; Humans ; Male ; Membrane Proteins/blood ; Middle Aged ; Receptors, CCR5/blood ; Receptors, CXCR3/blood ; Risk Factors
Czasopismo naukowe
Tytuł :
Unintentional human leukocyte antigen-mismatched haematopoietic cell transplant: clinical course and root cause analysis.
Autorzy :
Bo A; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Raiola AM; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Gualandi F; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Orengo G; Quality and risk management, accreditation and pr, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Dapino P; Quality and risk management, accreditation and pr, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Gianelli Castiglione A; Legal medicine, IRCCS Ospedale Policlinico San Martino, Genova, Coordinamento Trapianti Regione Liguria, Genova, Italy.
Angelucci E; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Oct; Vol. 191 (1), pp. e35-e37. Date of Electronic Publication: 2020 Jul 21.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
HLA Antigens*
Medical Errors*
Peripheral Blood Stem Cell Transplantation*
Transplantation Conditioning*
Leukemia, Myeloid, Acute/*therapy
Allografts ; Humans ; Leukemia, Myeloid, Acute/blood ; Male ; Middle Aged
Raport
Tytuł :
Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.
Autorzy :
Elchuri SV; Department of Pediatrics, Division of Endocrinology and Metabolism, NE Atlanta, GA.
Williamson Lewis R; Division of Pediatric Hematology/Oncology/BMT, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta.
Quarmyne MO; Division of Pediatric Hematology/Oncology/BMT, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta.
Haight AE; Division of Pediatric Hematology/Oncology/BMT, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta.
Cottrell HN; Department of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, NE Atlanta, GA.
Meacham LR; Department of Pediatrics, Division of Endocrinology and Metabolism, NE Atlanta, GA.; Division of Pediatric Hematology/Oncology/BMT, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2020 Oct; Vol. 42 (7), pp. e575-e582.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Sickle Cell/*therapy
Hematopoietic Stem Cell Transplantation/*methods
Hypogonadism/*epidemiology
Hypogonadism/*etiology
Transplantation Conditioning/*adverse effects
Alkylating Agents/adverse effects ; Anti-Mullerian Hormone/blood ; Child ; Female ; Humans ; Longitudinal Studies ; Luteinizing Hormone/blood ; Male ; Ovarian Reserve/drug effects ; Primary Ovarian Insufficiency/chemically induced ; Retrospective Studies ; Testosterone/blood ; Transplantation Conditioning/methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies